CNI-free "Bottom"-up Immunosuppression in Patients Undergoing Liver Transplantation

NCT01023542 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

UNKNOWN

Status

45

Enrollment

OTHER

Sponsor class

Conditions

Renal Impairment
Liver Transplantation
Everolimus

Interventions

DRUG: delayed, low-dose CNI
DRUG: BU-CNI
DRUG: BU-Everolimus

Sponsor

University of Regensburg

Collaborators

[object Object]